Esha Kadam

Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey

C. Caballero-Uribe, A. Makol, T. Velikova, 2024, Rheumatology Advances in Practice.

Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.

C. Caballero-Uribe, A. Makol, T. Velikova, 2024, International journal of rheumatic diseases.

COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus

W. Katchamart, S. Shaharir, M. Dey, 2023, Journal of clinical medicine.

COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group

C. Caballero-Uribe, T. Velikova, J. Knitza, 2023, Rheumatology international.

Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort

A. Makol, E. Nikiphorou, M. Kuwana, 2023, Rheumatology International.

Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges

A. Makol, T. Velikova, N. Ziadé, 2024, International journal of rheumatic diseases.